New York, NY -- March 17, 2022 -- InvestorsHub NewsWire -- via Traders News Source, a leading independent equity research and corporate access firm focused on small cap growth companies issues new research.

Northwest Biotherapeutics, Inc. (OTCQB: NWBO) a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, after spending years in preparation, is now operating under the UK Medicines and Healthcare Products Regulatory Agency (MHRA) license for manufacture of GMP (clinical grade) cell therapy products. The company is in production of its first dendritic cell cancer vaccine. The company developing electro-optic polymers to transmit data at higher speeds with less power, Lightwave Logic, Inc. (NASDAQ: LWLG) has received a new U.S. patent on an invention that will simplify modulator integration for high-volume foundry manufacturing operations while enhancing polymer reliability to enable a more effective photonic engine. U.S. Patent number 11,262,605 illustrates the design of a monolithic photonic integrated circuit (PIC) that utilizes very high speed, low power proprietary polymer modulators that will enable much faster data rates for data communications, telecommunications, and data rich environments.

Where will this new license take NWBO in product development and what exactly did LWLG just get patented? READ MORE Copy and paste to browser may be required -
TNS Feature NFT and Metaverse Report 

Emerging electric vehicle manufacturer, Mullen Automotive, Inc. (NASDAQ: MULN) announced an update on their next-generation solid-state polymer battery technology, which is a significant advancement over today’s current lithium-Ion batteries. Data collected from solid-state cell testing shows impressive results, including a range of 600-plus miles on a full charge and over 300 miles of range delivered in 18 minutes with DC fast charging. TPT Global Tech, Inc. (OTCQB: TPTW) has announced that it intends to partner with the City of Tuskegee Alabama to locate and invest in the development, management, and operation of a "Smart City". The City of Tuskegee is offering the Joint Partnership land, as needed, and proposes to support the financing of the project through Municipal Bonds. Completion of the project, estimated to be in three years, should add to the State's GDP while bringing jobs directly and indirectly to the region and creating a self-sustaining ecosystem.

Does the new battery tech at MULN signal the end of lithium-ion batteries and what will the TPTW smart city look like? READ MORE Copy and paste to browser may be required -
TNS Feature NFT and Metaverse Report 


Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ, and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TNS LLC has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a chartered financial analyst, for further information on analyst credentials, please email TNS LLC provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer be featured on our coverage list, contact us via email at:

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Traders News Source


Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Dec 2022 to Jan 2023 Click Here for more Northwest Biotherapeutics (QB) Charts.
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Jan 2022 to Jan 2023 Click Here for more Northwest Biotherapeutics (QB) Charts.